387 related articles for article (PubMed ID: 9022079)
41. Caloric restriction decreases age-dependent accumulation of the glycoxidation products, N epsilon-(carboxymethyl)lysine and pentosidine, in rat skin collagen.
Cefalu WT; Bell-Farrow AD; Wang ZQ; Sonntag WE; Fu MX; Baynes JW; Thorpe SR
J Gerontol A Biol Sci Med Sci; 1995 Nov; 50(6):B337-41. PubMed ID: 7583789
[TBL] [Abstract][Full Text] [Related]
42. Antibodies against advanced glycation end product Nepsilon-(carboxymethyl)lysine in healthy controls and diabetic patients.
Vay D; Vidali M; Allochis G; Cusaro C; Rolla R; Mottaran E; Bellomo G; Albano E
Diabetologia; 2000 Nov; 43(11):1385-8. PubMed ID: 11126407
[TBL] [Abstract][Full Text] [Related]
43. Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen.
Dunn JA; McCance DR; Thorpe SR; Lyons TJ; Baynes JW
Biochemistry; 1991 Feb; 30(5):1205-10. PubMed ID: 1899338
[TBL] [Abstract][Full Text] [Related]
44. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins.
Ahmed MU; Brinkmann Frye E; Degenhardt TP; Thorpe SR; Baynes JW
Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):565-70. PubMed ID: 9182719
[TBL] [Abstract][Full Text] [Related]
45. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage.
Meng J; Sakata N; Takebayashi S; Asano T; Futata T; Nagai R; Ikeda K; Horiuchi S; Myint T; Taniguchi N
Atherosclerosis; 1998 Feb; 136(2):355-65. PubMed ID: 9543107
[TBL] [Abstract][Full Text] [Related]
46. N(omega)-(carboxymethyl)lysine depositions in human aortic heart valves: similarities with atherosclerotic blood vessels.
Baidoshvili A; Niessen HW; Stooker W; Huybregts RA; Hack CE; Rauwerda JA; Meijer CJ; Eijsman L; van Hinsbergh VW; Schalkwijk CG
Atherosclerosis; 2004 Jun; 174(2):287-92. PubMed ID: 15136058
[TBL] [Abstract][Full Text] [Related]
47. Increased accumulation of protein-bound N(ε)-(carboxymethyl)lysine in tissues of healthy rats after chronic oral N(ε)-(carboxymethyl)lysine.
Li M; Zeng M; He Z; Zheng Z; Qin F; Tao G; Zhang S; Chen J
J Agric Food Chem; 2015 Feb; 63(5):1658-63. PubMed ID: 25611617
[TBL] [Abstract][Full Text] [Related]
48. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.
Reddy S; Bichler J; Wells-Knecht KJ; Thorpe SR; Baynes JW
Biochemistry; 1995 Aug; 34(34):10872-8. PubMed ID: 7662668
[TBL] [Abstract][Full Text] [Related]
49. New biomarkers of Maillard reaction damage to proteins.
Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
[TBL] [Abstract][Full Text] [Related]
50. 2-aminoadipic acid is a marker of protein carbonyl oxidation in the aging human skin: effects of diabetes, renal failure and sepsis.
Sell DR; Strauch CM; Shen W; Monnier VM
Biochem J; 2007 Jun; 404(2):269-77. PubMed ID: 17313367
[TBL] [Abstract][Full Text] [Related]
51. Autoantibody against N(epsilon)-(carboxymethyl)lysine: an advanced glycation end product of the Maillard reaction.
Shibayama R; Araki N; Nagai R; Horiuchi S
Diabetes; 1999 Sep; 48(9):1842-9. PubMed ID: 10480617
[TBL] [Abstract][Full Text] [Related]
52. Prevention of age-induced N(ε)-(carboxymethyl)lysine accumulation in the microvasculature.
Fuijkschot WW; de Graaff HJ; Berishvili E; Kakabadze Z; Kupreishvili K; Meinster E; Houtman M; van Broekhoven A; Schalkwijk CG; Vonk AB; Krijnen PA; Smulders YM; Niessen HW
Eur J Clin Invest; 2016 Apr; 46(4):334-41. PubMed ID: 26842530
[TBL] [Abstract][Full Text] [Related]
53. Photo-enhanced modification of human skin elastin in actinic elastosis by N(epsilon)-(carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction.
Mizutari K; Ono T; Ikeda K; Kayashima K; Horiuchi S
J Invest Dermatol; 1997 May; 108(5):797-802. PubMed ID: 9129235
[TBL] [Abstract][Full Text] [Related]
54. Carboxymethyllysine in dermal tissues of diabetic and nondiabetic patients with chronic renal failure: relevance to glycoxidation damage.
Meng J; Sakata N; Imanaga Y; Takebayashi S; Nagai R; Horiuchi S
Nephron; 2001 May; 88(1):30-5. PubMed ID: 11340347
[TBL] [Abstract][Full Text] [Related]
55. The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions.
Fu MX; Requena JR; Jenkins AJ; Lyons TJ; Baynes JW; Thorpe SR
J Biol Chem; 1996 Apr; 271(17):9982-6. PubMed ID: 8626637
[TBL] [Abstract][Full Text] [Related]
56. Hydroxyl radical mediates N epsilon-(carboxymethyl)lysine formation from Amadori product.
Nagai R; Ikeda K; Higashi T; Sano H; Jinnouchi Y; Araki T; Horiuchi S
Biochem Biophys Res Commun; 1997 May; 234(1):167-72. PubMed ID: 9168983
[TBL] [Abstract][Full Text] [Related]
57. Elevation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in patients presenting with acute myocardial infarction.
Kralev S; Zimmerer E; Brueckmann M; Lang S; Kälsch T; Rippert A; Lin J; Borggrefe M; Hammes HP; Süselbeck T
Clin Chem Lab Med; 2009; 47(4):446-51. PubMed ID: 19278364
[TBL] [Abstract][Full Text] [Related]
58. Immunohistochemistry of advanced glycation end product N
Nogami M; Hoshi T; Toukairin Y; Arai T; Nishio T
BMC Res Notes; 2020 May; 13(1):239. PubMed ID: 32398121
[TBL] [Abstract][Full Text] [Related]
59. The presence of N(ε)-(Carboxymethyl) lysine in the human epidermis.
Kawabata K; Yoshikawa H; Saruwatari K; Akazawa Y; Inoue T; Kuze T; Sayo T; Uchida N; Sugiyama Y
Biochim Biophys Acta; 2011 Oct; 1814(10):1246-52. PubMed ID: 21708295
[TBL] [Abstract][Full Text] [Related]
60. Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl)lysine is increased in uremia.
Degenhardt TP; Grass L; Reddy S; Thorpe SR; Diamandis EP; Baynes JW
Kidney Int; 1997 Oct; 52(4):1064-7. PubMed ID: 9328946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
